FDA approves BeOne's (ONC) BRUKINSA tablet Jun 11, 2025 04:05PM
BeiGene (BGNE) Announces TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy Dec 27, 2024 06:01AM
BeiGene (BGNE) Receives Israeli Ministry of Health Approval for TEVIMBRA for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy Sep 17, 2024 07:01AM